Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

11,749

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

11,749 results for “patient safety”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov40/100

Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients

ClinicalTrials.gov study NCT03623243. IPD Sharing: YES. Countries: 2. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.

ClinicalTrials.gov study NCT02792231. IPD Sharing: YES. Countries: 30. Publications: 4.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies

ClinicalTrials.gov study NCT03637764. IPD Sharing: YES. Countries: 8. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)

ClinicalTrials.gov study NCT04504825. IPD Sharing: YES. Countries: 19. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid

ClinicalTrials.gov study NCT04206553. IPD Sharing: YES. Countries: 9. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma

ClinicalTrials.gov study NCT02571777. IPD Sharing: UNDECIDED. Countries: 41. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov40/100

Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises

ClinicalTrials.gov study NCT01895361. IPD Sharing: YES. Countries: 3. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

ClinicalTrials.gov study NCT04864392. IPD Sharing: YES. Countries: 15. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder

ClinicalTrials.gov study NCT04041284. IPD Sharing: YES. Countries: 13. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involveme

ClinicalTrials.gov study NCT00920647. IPD Sharing: YES. Countries: 2. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients

ClinicalTrials.gov study NCT02435849. IPD Sharing: YES. Countries: 11. Publications: 7.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD

ClinicalTrials.gov study NCT03919162. IPD Sharing: YES. Countries: 1. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD

ClinicalTrials.gov study NCT03954626. IPD Sharing: YES. Countries: 2. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

ClinicalTrials.gov study NCT02460224. IPD Sharing: UNDECIDED. Countries: 12. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov40/100

PoC Study to Evaluate the Efficacy and Safety of Secukinumab 300 mg in Patients With Lichen Planus

ClinicalTrials.gov study NCT04300296. IPD Sharing: YES. Countries: 3. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

ClinicalTrials.gov study NCT00782067. IPD Sharing: UNDECIDED. Countries: 12. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov40/100

Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm

ClinicalTrials.gov study NCT04362137. IPD Sharing: YES. Countries: 12. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa

ClinicalTrials.gov study NCT03019406. IPD Sharing: YES. Countries: 5. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A

ClinicalTrials.gov study NCT04759131. IPD Sharing: YES. Countries: 15. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients

ClinicalTrials.gov study NCT02649218. IPD Sharing: UNDECIDED. Countries: 10. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record